Back to front
Section

Business

Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.

Goldman Sachs reiterates a Buy rating on Eli Lilly, pointing to progress in obesity drug development
The Apex Times

THE APEX TIMES

More Stories